External validation of a screening instrument to identify cardiometabolic predictors of mortality in individuals with cancer

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

Background: Cancer survivors are at risk of higher mortality from other causes, in particular, cardiovascular and metabolic. We have previously reported on a development of a brief screening instrument to identify cardiometabolic predictors of mortality in older individuals using the Australian Longitudinal Study of Ageing, which showed that age, sex, history of cerebrovascular disease, non-adherence to exercise guidelines, and smoking predicted for mortality(Lim et al. 2017). The objective of this study was to validate our findings using an external database.
Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Volume36
Issue number30 Supp
DOIs
Publication statusPublished - 20 Oct 2018
Event2018 American Society of Clinical Oncology Quality Care Symposium - Phoenix, United States
Duration: 28 Sept 201829 Sept 2018

Keywords

  • Cardiometabolic
  • Mortality predictors
  • Camcer

Fingerprint

Dive into the research topics of 'External validation of a screening instrument to identify cardiometabolic predictors of mortality in individuals with cancer'. Together they form a unique fingerprint.

Cite this